
Sign up to save your podcasts
Or


A Note from James:
One of my favorite conversations on this show was with Peter Thiel. Yes—PayPal, Facebook, Palantir, and a dozen other hits. I first ran this episode years ago, and the advice still holds up. The same stories, the same frameworks—and the same challenge to think from first principles. Here’s Peter Thiel, one of the most influential entrepreneurs of our time.
Episode Description:
In this redux, James pressure-tests the core ideas from Peter Thiel’s Zero to One—why competition is for losers, how real monopolies are built, and why starting “narrow” is often the only path to something huge. They cover Facebook’s early moat (real identity), PayPal’s network-effect wedge on eBay, and the “10x or nothing” bar for proprietary technology. Peter shares a contrarian read on bubbles, why biotech’s slump may be opportunity, and how to hire, divide roles, and keep teams from fighting. The through-line: seek secrets, combine disciplines, and make something so different that it becomes its own category.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By James Altucher4.6
24772,477 ratings
A Note from James:
One of my favorite conversations on this show was with Peter Thiel. Yes—PayPal, Facebook, Palantir, and a dozen other hits. I first ran this episode years ago, and the advice still holds up. The same stories, the same frameworks—and the same challenge to think from first principles. Here’s Peter Thiel, one of the most influential entrepreneurs of our time.
Episode Description:
In this redux, James pressure-tests the core ideas from Peter Thiel’s Zero to One—why competition is for losers, how real monopolies are built, and why starting “narrow” is often the only path to something huge. They cover Facebook’s early moat (real identity), PayPal’s network-effect wedge on eBay, and the “10x or nothing” bar for proprietary technology. Peter shares a contrarian read on bubbles, why biotech’s slump may be opportunity, and how to hire, divide roles, and keep teams from fighting. The through-line: seek secrets, combine disciplines, and make something so different that it becomes its own category.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

16,174 Listeners

3,347 Listeners

2,672 Listeners

7,216 Listeners

5,007 Listeners

2,221 Listeners

4,726 Listeners

8,043 Listeners

4,942 Listeners

2,660 Listeners

29,272 Listeners

602 Listeners

989 Listeners

9 Listeners

229 Listeners